Асосий контентга ўтиш
AkademIndex

Маҳсулотлар

Ишлаб чиқувчилар учун

AkademBaseЭкотизим учун очиқ API
Мақола

Graph Neural Networks for Network-Based Biomarker Discovery in Complex Diseases

S. AnuradhaMR Deemed to be University,Department of Electronics and Comm. Engineering,Hyderabad,IndiaSujaya B. LB.N.M. Institute of Technology (BNMIT),Department of Electronics and Communication Engineering,Bengaluru,IndiaDeepak GuptaITM Gwalior,Department of Computer Science and Engineering,Gwalior,Madhya Pradesh,IndiaKayumova ShakhnozaTermez University of Economics and Service,Department of Medical Fundamental Sciences,Termez,UzbekistanMuyassar AllaberganovaUrgench State University,Department of Data Transmission Networks and Systems,Urgench,UzbekistanSardor Sabirov
2025
ABI

Аннотация

Network-based biomarker discovery in complex diseases faces significant challenges due to the intricate interplay of molecular interactions and multi-omics data heterogeneity. This paper introduces a comprehensive graph neural network (GNN) framework that integrates protein-protein interaction networks with multi-omics datasets to identify disease-specific biomarkers. Our approach employs graph convolutional networks (GCN) with attention mechanisms and variational graph autoencoders for learning hierarchical representations of biological networks. We implement a multi-scale architecture combining node-level, subgraph-level, and graph-level features to capture local and global network topology. The framework achieves 94.7% accuracy in cancer type classification across 33 cancer types using TCGA datasets, 89.4% accuracy in Alzheimer’s disease biomarker identification from ROSMAP cohorts, and 93.5% precision in cardiovascular disease gene prediction. Validation on five independent datasets including TCGA, GTEx, STRING, DisGeNET, and ADNI demonstrates superior performance compared to traditional machine learning methods, with 15-40% improvement in F1-scores. The discovered biomarkers show strong biological relevance with pathway enrichment p-values below 10-15. Our framework enables interpretable biomarker discovery through attention weight analysis and graph explain-ability methods, facilitating translation to clinical applications.

Ҳали таржима қилинмаган

Мавзулар

Идентификаторлар

Иқтибослар ва манбалар

Кўрсаткичлар — AkademScholar · Тез орада